Document is current

Impact of Saroglitazar as an add-on therapy to rosuvastatin in patients with diabetic dyslipidemia: A prospective, single centre, observational study in Indian patients

Crossref DOI link: https://doi.org/10.53022/oarjst.2024.10.1.0080

Published Online: 2024-01-30

Update policy: https://doi.org/10.53022/oarj.ourcrossmarkpolicy